Demodex Blepharitis Treatment Study

Completed · Phase 1 · Has a placebo group

Conditions studied: Chronic Blepharitis

In brief

This is a randomized clinical trial to determine the safety and efficacy of terpinen-4-ol (T4O), the most active ingredient of tea tree oil (TTO), in eradicating ocular demodicosis (reducing ocular demodex counts and achieving the clinical improvement with minimal or no irritation).

Key facts

Study ID
NCT01647217
Run by
BioTissue Holdings, Inc
People needed
17
Starts
2014-02-01
Expected to finish
2015-07-01
Last updated by the study team
2017-07-26

Who can join

Age: 15 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.